Anatara Lifesciences Limited, based in Carlton, Australia, is a research and development company that focuses on evidence-based solutions for gastrointestinal diseases in both humans and animals. Its flagship product, Gastrointestinal ReProgramming (GaRP), is a proprietary formulation that targets primary underlying factors related to gastrointestinal conditions such as irritable bowel syndrome and inflammatory bowel disease. Additionally, the company has developed Detach, a treatment for diarrhea in piglets, and is working on bromelain-based formulations for piglets and poultry. Anatara Lifesciences Limited was founded in 2010.
Anatara Lifesciences Limited's ticker is ANR
The company's shares trade on the ASX stock exchange
They are based in Carlton, Australia
There are 1-10 employees working at Anatara Lifesciences Limited
It is https://anataralifesciences.com/
Anatara Lifesciences Limited is in the Healthcare sector
Anatara Lifesciences Limited is in the Biotechnology industry
The following five companies are Anatara Lifesciences Limited's industry peers: